Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Condition(s):Adenovirus; Primary Immune Deficiency DisorderLast Updated:October 25, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Adenovirus; Primary Immune Deficiency DisorderLast Updated:October 25, 2023Recruiting
Condition(s):Tuberous Sclerosis ComplexLast Updated:March 6, 2024Recruiting
Condition(s):Hypertension; Neurofibromatosis 1; Blood PressureLast Updated:April 27, 2023Completed
Condition(s):Neurofibromatosis Type 1; Plexiform NeurofibromaLast Updated:December 21, 2023Active, not recruiting
Condition(s):Neurofibromatosis 1Last Updated:July 25, 2022Active, not recruiting
Condition(s):Tuberous Sclerosis ComplexLast Updated:December 29, 2023Enrolling by invitation
Condition(s):Neurofibromatosis 1; Neurofibroma, PlexiformLast Updated:October 2, 2023Completed
Condition(s):Neurocognitive Deficit; Mental Health Impairment; Neurofibromatosis 1Last Updated:September 22, 2023Completed
Condition(s):Neonatal Respiratory DistressLast Updated:March 5, 2024Not yet recruiting
Condition(s):NeurofibromatosisLast Updated:August 1, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.